Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in Enlivex Ltd. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q3 2023
- Shares held
- 188.5K
- −69.2K (−26.9%) vs. Q3 2023
- Total value
- $509.2K
- +$100.8K (+24.7%) vs. Q3 2023
- New holders
- 3
- 4 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 62,089 | $168.0K | 0.00% | +3,200+5.4% | Added |
| Morgan Stanley | 44,460 | $120.0K | 0.00% | +304+0.7% | Added |
| Susquehanna International Group, LLP | 27,925 | $75.4K | 0.00% | +27,925 | New |
| Edmond de Rothschild Holding S.A. | 13,000 | $35.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,420 | $28.1K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 9,993 | $27.0K | 0.00% | +1,111+12.5% | Added |
| Citadel Advisors LLC | 7,086 | $19.1K | 0.00% | −30,597−81.2% | Reduced |
| Citigroup Inc | 4,724 | $12.8K | 0.00% | +4,724 | New |
| UBS Group AG | 3,663 | $9.89K | 0.00% | +2,973+430.9% | Added |
| Steward Partners Investment Advisory, LLC | 3,000 | $8.10K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1,000 | $2.70K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 400 | $1.08K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 266 | $718 | 0.00% | −572−68.3% | Reduced |
| JPMorgan Chase & Co | 237 | $640 | 0.00% | −963−80.3% | Reduced |
| Red Tortoise LLC | 150 | $405 | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 43 | $116 | 0.00% | +43 | New |
| Qube Research & Technologies Ltd | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Compagnie Lombard Odier SCmA | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Susquehanna International Group Ltd. | 0 | $0 | 0.00% | −12,326−100.0% | Sold out |